| A Study of ALXN1830 in Healthy Adult Participants (NCT04730804) | Alexion Pharmaceuticals, Inc. | 2021-03-17 |
| Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis (NCT04480086) | AbbVie | 2021-03-17 |
| Safety and Efficacy of Trans Sodium Crocetinate (TSC) in Enhancing Tissue Oxygen Levels in Healthy Volunteers (NCT04808622) | Diffusion Pharmaceuticals Inc | 2021-03-17 |
| Safety, Tolerability and Pharmacokinetic Profile of SYL1801 Eye Drops (NCT04782271) | Sylentis, S.A. | 2021-03-17 |
| A Study of Single Ascending Doses of PF-07258669 in Healthy Adult Participants (NCT04628793) | Pfizer | 2021-03-16 |
| A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease (NCT04335721) | University of Illinois at Chicago | 2021-03-16 |
| TEMOkids Study : A Phase I Pediatric Study for KIMOZO, Oral Suspension of Temozolomide (NCT04610736) | Orphelia Pharma | 2021-03-16 |
| A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101) (NCT06189391) | MSD R&D (China) Co., Ltd. | 2021-03-16 |
| PEP on a Skin Graft Donor Site Wound (NCT04664738) | Rion Inc. | 2021-03-16 |
| Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis (NCT04724980) | Precigen, Inc | 2021-03-16 |
| Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions (NCT04607850) | Barinthus Biotherapeutics | 2021-03-16 |
| Study to Evaluate D-1553 in Subjects With Lung Cancer (NCT05383898) | InventisBio Co., Ltd | 2021-03-16 |
| Clinical Study of VG161 in Subjects with Advanced Primary Liver Cancer (NCT04806464) | CNBG-Virogin Biotech (Shanghai) Ltd. | 2021-03-16 |
| A Study to Evaluate RMC-035 in Subjects Undergoing Cardiac Surgery (NCT04829916) | Guard Therapeutics AB | 2021-03-16 |
| DDI Study of ASC41 in HV and the PK, Safety and Tolerability in Subjects With NAFLD. (NCT04845646) | Gannex Pharma Co., Ltd. | 2021-03-16 |
| Phase I Double-blind, Placebo-controlled Study of AZD7442 (NCT04896541) | AstraZeneca | 2021-03-16 |
| Olanzapine for the Prevention of Postoperative Nausea and Vomiting (NCT04718727) | Amani Hassan Abdel-Wahab | 2021-03-15 |
| Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV with Hemophilia. (NCT04688034) | Kiminori Kimura, MD | 2021-03-15 |
| Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema (NCT04225611) | Massachusetts Eye and Ear Infirmary | 2021-03-15 |
| ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors (NCT04645069) | Adagene Inc | 2021-03-15 |
| Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV) (NCT04799353) | AbbVie | 2021-03-15 |
| Effects of Stulln and Accommodative Training (NCT05107791) | Pacific University | 2021-03-15 |
| Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease (NCT04639050) | Hoffmann-La Roche | 2021-03-15 |
| A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya (NCT04826094) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-03-15 |
| Study on the Bioavailability of SHR0302 in Healthy Subjects (NCT04712838) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-15 |
| A Study to Test Different Doses of BI 3011441 in Japanese People With Different Types of Advanced Cancer (NRAS/KRAS Mutation Positive) (NCT04742556) | Boehringer Ingelheim | 2021-03-15 |
| Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a (NCT04773665) | VBI Vaccines Inc. | 2021-03-15 |
| A Study of GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL (NCT04595162) | Peking University Third Hospital | 2021-03-15 |
| Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects (NCT04821674) | Daiichi Sankyo Co., Ltd. | 2021-03-15 |
| Study to Assess the Safety and Efficacy of Enbrel Administered by Sofusa DoseConnect for Rheumatoid Arthritis (NCT04559412) | Sorrento Therapeutics, Inc. | 2021-03-15 |
| Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain (NCT04713189) | Lee's Pharmaceutical Limited | 2021-03-15 |
| Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy (NCT04826328) | Pacira Pharmaceuticals, Inc | 2021-03-15 |
| Potassium Binder in CKD Patients (With Hyperkalemia) (DiPo Trial) (NCT04727840) | Brigham and Women's Hospital | 2021-03-15 |
| The Use of Adhesion Molecule Loaded Hydrogel With Minimally Invasive Surgical Technique in Treatment of Periodontal Intrabony Defect (NCT05653245) | Minia University | 2021-03-15 |
| A Study to Explore the Effect of Food Before a Single Dose of Sitravatinib (NCT04800614) | Mirati Therapeutics Inc. | 2021-03-15 |
| Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors (NCT04742959) | TransThera Sciences (Nanjing), Inc. | 2021-03-14 |
| The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers (NCT04914221) | Jeil Pharmaceutical Co., Ltd. | 2021-03-13 |
| Bioequivalence of Ezetimibe Tablets in Healthy Subjects (NCT04814589) | Cao Yu | 2021-03-13 |
| Pharmacokinetics and Safety of DWJ1451 in Healthy Adults (NCT04819932) | Daewoong Pharmaceutical Co. LTD. | 2021-03-13 |
| A Study of of HOT1030 in Patients With Advanced Solid Tumors (NCT05060263) | Huabo Biopharm Co., Ltd. | 2021-03-12 |
| Infusions of Mesenchymal Stromal Cells in Children With Multisystem Inflammatory Syndrome (NCT04549285) | Joanne Kurtzberg, MD | 2021-03-12 |
| Evaluate CART-BCMA in Patients With Relapsed and/or Refractory Multiple Myeloma (NCT05346198) | Shanghai Simnova Biotechnology Co.,Ltd. | 2021-03-12 |
| Safety, Tolerability, and Pharmacokinetics of Inhaled Virazole Administered Via Air-Jet Nebulizer in Healthy Volunteers (NCT05229510) | Bausch Health Americas, Inc. | 2021-03-12 |
| Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy Subjects (NCT04871724) | Enanta Pharmaceuticals, Inc | 2021-03-12 |
| Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer. (NCT04632199) | Ipsen | 2021-03-12 |
| Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers (NCT04782505) | Daewoong Pharmaceutical Co. LTD. | 2021-03-12 |
| First-in-Human Study of TSHA-101 Gene Therapy for Treatment of Infantile Onset GM2 Gangliosidosis (NCT04798235) | Dr. Anupam Sehgal | 2021-03-12 |
| Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective Disorder (NCT04779177) | Intra-Cellular Therapies, Inc. | 2021-03-12 |
| A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma (NCT04722146) | Janssen Research & Development, LLC | 2021-03-12 |
| Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older (NCT04798027) | Sanofi Pasteur, a Sanofi Company | 2021-03-12 |
| This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease (NCT05266014) | RBP4 Pty Ltd | 2021-03-12 |
| NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery (NCT04588038) | Hyunseok Kang, MD | 2021-03-12 |
| A Study to Evaluate the Effect of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Sitravatinib (NCT04772612) | Mirati Therapeutics Inc. | 2021-03-12 |
| Low Dose IL-2 for the Treatment of Crohn's Disease (NCT04263831) | Boston Children's Hospital | 2021-03-11 |
| Study of ADG106 In Combination With PD-1 Antibody In Advanced or Metastatic Solid Tumors and/or Non Hodgkin Lymphoma (NCT04775680) | Adagene (Suzhou) Limited | 2021-03-11 |
| A Study of EMB-02 in Participants With Advanced Solid Tumors (NCT04618393) | Shanghai EpimAb Biotherapeutics Co., Ltd. | 2021-03-11 |
| Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19 (NCT04803227) | Histogen | 2021-03-11 |
| A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19 (NCT04813796) | ModernaTX, Inc. | 2021-03-11 |
| Safety and Tolerability of COVID-19 Vaccine (ABNCoV2) (NCT04839146) | Radboud University Medical Center | 2021-03-11 |
| To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers (NCT04783636) | Peptron, Inc. | 2021-03-11 |
| A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Digoxin (P-Glycoprotein Substrate) in Healthy Participants (NCT06194214) | Eli Lilly and Company | 2021-03-11 |
| RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome) (NCT04571970) | REGENXBIO Inc. | 2021-03-11 |
| Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia (NCT04742101) | Institut de Recherches Internationales Servier | 2021-03-10 |
| Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES). (NCT04721691) | Northwell Health | 2021-03-10 |
| UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL (NCT04544592) | University of Colorado, Denver | 2021-03-10 |
| A Study of Injection HB0025 in Patients With Advanced Solid Tumors (NCT04678908) | Huabo Biopharm Co., Ltd. | 2021-03-10 |
| YQ23 Study in Patients With Critical Limb Ischaemia (NCT04792008) | New Beta Innovation Limited | 2021-03-10 |
| A Study to Evaluate the Long-term Safety of Patients With Advanced Lymphoid Leukemia Who Have Been Previously Administered With UCART19 (NCT02735083) | Institut de Recherches Internationales Servier | 2021-03-10 |
| Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT04761705) | JeniVision, Inc. | 2021-03-10 |
| Phase I Clinical Trial of CT0180 Cells in the Treatment of Hepatocellular Carcinoma (NCT04756648) | Zhejiang University | 2021-03-10 |
| A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors (NCT04617314) | RemeGen Co., Ltd. | 2021-03-10 |
| Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies (NCT04796688) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2021-03-10 |
| Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) (NCT04666649) | University of Maryland, Baltimore | 2021-03-10 |
| Evaluation of the Absolute Bioavailability and Mass Balance of CHF6001 (Tanimilast) in Healthy Subjects (NCT04756960) | Chiesi Farmaceutici S.p.A. | 2021-03-10 |
| A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1) (NCT04830800) | Institute of Vaccines and Medical Biologicals, Vietnam | 2021-03-10 |
| A Pharmacokinetic Similarity Study in Healthy Male Subjects to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of LY06006 Versus US-Prolia and EU-Prolia by Single-dose Subcutaneous Injection (NCT06095427) | Luye Pharma Group Ltd. | 2021-03-09 |
| A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild Asthma (NCT04802746) | UCB Biopharma SRL | 2021-03-09 |
| Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer (NCT06048705) | Adaptimmune | 2021-03-09 |
| NeoTIL in Advanced Solid Tumors (NCT04643574) | Centre Hospitalier Universitaire Vaudois | 2021-03-09 |
| TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid Tumor (NCT04862767) | Autotelicbio | 2021-03-09 |
| Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC (NCT04686305) | AstraZeneca | 2021-03-09 |
| Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Dostarlimab (GSK4057190) in Participants With RRMM (NCT06655818) | GlaxoSmithKline | 2021-03-09 |
| Effect of Estetrol Monohydrate (E4) on QTc Interval (NCT04819906) | Estetra | 2021-03-09 |
| Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors (NCT04777994) | Calico Life Sciences LLC | 2021-03-09 |
| Regional Scalp Block Versus IV Parecoxib for Post-operative Cranioplasty Surgery Pain: A Comparison of Pain Score. (NCT05442411) | Universiti Sains Malaysia | 2021-03-09 |
| Comparative Bioavailability of Risperidone. (NCT05179525) | Rovi Pharmaceuticals Laboratories | 2021-03-09 |
| Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment (NCT05101265) | PharmaMar | 2021-03-09 |
| Study of AT-752 in Healthy Subjects (NCT04722627) | Atea Pharmaceuticals, Inc. | 2021-03-09 |
| A Study of KF-0210 in Advanced Solid Tumors Patients (NCT04713891) | Keythera Pharmaceuticals (Australia) Pty Ltd | 2021-03-09 |
| Safety of SP-420 in the Treatment of Transfusional Iron Overload (NCT04741542) | The University of Texas Health Science Center at San Antonio | 2021-03-09 |
| A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder (NCT04786730) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2021-03-09 |
| GEN3014 Trial in Relapsed or Refractory Hematologic Malignancies (NCT04824794) | Genmab | 2021-03-09 |
| PM8002 in the Treatment of Patients With Advanced Solid Tumors (NCT05918445) | Biotheus Inc. | 2021-03-09 |
| A Study of JNJ-70033093 (BMS-986177) in Healthy Chinese Adult Participants (NCT04569695) | Janssen Research & Development, LLC | 2021-03-08 |
| Intratumoral Cisplatin for Resectable NSCLC (NCT04809103) | University of Vermont | 2021-03-08 |
| A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer (NCT04844073) | Takeda | 2021-03-08 |
| Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor (NCT04616560) | National Cancer Institute (NCI) | 2021-03-08 |
| Study to Assess the Safety, Tolerability, and Pharmacokinetics of PXL770 in Healthy Subjects. (NCT05441904) | Poxel SA | 2021-03-08 |
| The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19 (NCT04805086) | Guy's and St Thomas' NHS Foundation Trust | 2021-03-08 |
| PE0116 Injection in Treatment of Patients With Advanced Solid Tumours (NCT05800249) | Shanghai HyaMab Biotech Co.,Ltd. | 2021-03-08 |